Althausen Peter L, Lapham Joan, Mead Lisa
*Reno Orthopaedic Clinic, Reno, NV; and †Department of Surgical Services Renown Regional Medical Center, Reno, NV.
J Orthop Trauma. 2016 Dec;30 Suppl 5:S37-S39. doi: 10.1097/BOT.0000000000000719.
Implant costs comprise the largest proportion of operating room supply costs for orthopedic trauma care. Over the years, hospitals have devised several methods of controlling these costs with the help of physicians. With increasing economic pressure, these negotiations have a tremendous ability to decrease the cost of trauma care. In the past, physicians have taken no responsibility for implant pricing which has made cost control difficult. The reasons have been multifactorial. However, industry surgeon consulting fees, research support, and surgeon comfort with certain implant systems have played a large role in slowing adoption of cost-control measures. With the advent of physician gainsharing and comanagement agreements, physicians now have impetus to change. At our facility, we have used 3 methods for cost containment since 2009: dual vendor, matrix pricing, and sole-source contracting. Each has been increasingly successful, resulting in massive savings for the institution. This article describes the process and benefits of each model.
植入物成本在创伤骨科护理的手术室供应成本中占比最大。多年来,医院在医生的帮助下设计了几种控制这些成本的方法。随着经济压力的增加,这些谈判在降低创伤护理成本方面具有巨大的能力。过去,医生对植入物定价不承担任何责任,这使得成本控制变得困难。原因是多方面的。然而,行业外科医生咨询费、研究支持以及外科医生对某些植入系统的偏好,在减缓成本控制措施的采用方面起到了很大作用。随着医生收益共享和共同管理协议的出现,医生现在有了改变的动力。在我们的机构,自2009年以来,我们使用了三种成本控制方法:双供应商、矩阵定价和独家采购合同。每种方法都越来越成功,为机构节省了大量资金。本文描述了每种模式的过程和益处。